Rai Staging System for Chronic Lymphocytic Leukemia (CLL)
Stages chronic lymphocytic leukemia, similar to Binet Staging System.
INSTRUCTIONS
Use in patients with lymphocytosis (absolute lymphocytes ≥15,000/mm³ in blood and ≥40% lymphocytes in marrow). Lymph nodes, spleen, and liver are considered enlarged if palpable on exam.
Stage 0
Rai Stage
Low risk
>10 years
Overall survival
Dr. Kanti R. Rai
About the creator
Kanti R. Rai, MD, is a principal investigator and professor at The Feinstein Institute for Medical Research in Manhasset, New York. He is also chief of the Chronic Lymphocytic Leukemia Research and Treatment Program at the North Shore-LIJ Cancer Institute. His primary research is focused on clinical leukemia and molecular therapy.
To view Dr. Kanti R. Rai's publications, visit PubMed
Are you Dr. Kanti R. Rai? Send us a message to review your photo and bio, and find out how to submit Creator Insights!
MDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients.